Novartis has announced its 2011 financial results, reporting a net sales increase of 16% to $58.6 billion, with a positive currency impact of 4% arising from the weakness of the US dollar against most major currencies during much of the year. Recently launched products sales grew by 38% over 2010 to $14.4 billion.
Last updated:
January 26
- RSS Feed
